Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a new build of the ClinicalTrials.gov page. This is a backend update that does not change the study details or data shown for NCT04541043.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the underlying version without altering displayed study information.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now shows revision v3.6.4, replacing v3.6.3. This appears to be a minor maintenance update without changes to study content or eligibility details.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the study details page.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision tag on the page changed from v3.6.0 to v3.6.2, signaling a recent content update. This is a metadata/version update rather than a change to the substantive study information.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now signals that recruitment has ended, and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also reformats the Intervention/Treatment heading and updates the revision version to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.